<DOC>
	<DOCNO>NCT02260830</DOCNO>
	<brief_summary>The purpose study investigate pharmacokinetic ( PK ) property various modify release tablet formulation Lu AF11167 ( Part A ) investigate pharmacokinetic ( PK ) property modify release tablet formulation Lu AF11167 feed fast state follow multiple dosing ( Part B ) .</brief_summary>
	<brief_title>Pharmacokinetic Properties Various Modified Release Tablet Formulations Lu AF11167</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Healthy men woman ≥18 ≤45 year age body mass index ( BMI ) &gt; 18.5 &lt; 30.0 kg/m2 . Women childbearing potential confirm nonpregnant nonlactating status . Other predefined inclusion exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>